Stock listing

Stuttgart:IGS1 IGC Pharma, Inc. Aktie

German listing (Stuttgart) of IGC Pharma, Inc. · home listing NYSE American:IGC

Follow IGC Pharma, Inc. into a list and get an email when it puts out news.

Home listing price · AMEX:IGC

$0.168 USD -0.027 (-13.7%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, AMEX:IGC

Past year -45.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.168 – $0.186 USDNov 20, 2026
Volume
500,330 sharesNov 20, 2026
Market cap
$19.60M USDAt the close on Nov 20, 2026 · price × 116.7M shares outstanding
52-week range
$0.080 – $0.360 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$167,876 USDMedian day 507,100 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
IGC Pharma, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NYSE American:IGC · Home$0.168 USD-0.027 (-13.7%)500,330$0.183$0.186$0.168$0.195Close on Nov 20, 2026
Frankfurt:IGS1€0.164 EUR-0.010 (-5.7%)—€0.164€0.164€0.164€0.174Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · AMEX:IGC · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.168-0.027-13.7%$0.183$0.186$0.168500,330
$0.195+0.007+3.6%$0.190$0.200$0.188678,535
$0.188+0.013+7.4%$0.177$0.189$0.175350,049
$0.175-0.001-0.6%$0.175$0.184$0.175427,758
$0.176-0.009-4.6%$0.189$0.189$0.168507,946
$0.185-0.014-7.2%$0.190$0.190$0.183364,001
$0.199+0.003+1.5%$0.195$0.200$0.191186,154
$0.196-0.008-4.1%$0.200$0.205$0.191203,860
$0.204+0.004+2.2%$0.194$0.206$0.193391,385
$0.200+0.011+5.8%$0.191$0.201$0.181589,981
$0.189-0.006-3.1%$0.197$0.197$0.179814,279
$0.195+0.009+4.8%$0.191$0.195$0.188323,169
$0.186-0.007-3.6%$0.193$0.200$0.185350,501
$0.193+0.008+4.3%$0.200$0.200$0.185397,910
$0.185-0.014-7.1%$0.191$0.197$0.181504,332
$0.199-0.040-16.5%$0.245$0.245$0.0802,007,404
$0.239-0.009-3.7%$0.250$0.251$0.238509,508
$0.248-0.002-0.8%$0.246$0.250$0.245118,314
$0.2500.0000.0%$0.245$0.253$0.243323,314
$0.2500.0000.0%$0.250$0.250$0.240124,200
$0.250+0.010+4.2%$0.250$0.250$0.240175,200
$0.240-0.010-4.0%$0.250$0.250$0.240364,800
$0.250+0.010+4.2%$0.240$0.250$0.240446,100
$0.240-0.010-4.0%$0.250$0.270$0.240541,100
$0.2500.0000.0%$0.260$0.260$0.240406,000
$0.2500.0000.0%$0.260$0.260$0.250781,400
$0.250-0.020-7.4%$0.260$0.260$0.250946,100
$0.270-0.010-3.6%$0.270$0.270$0.260422,100
$0.2800.0000.0%$0.280$0.290$0.270573,000
$0.2800.0000.0%$0.280$0.280$0.280232,200
$0.2800.0000.0%$0.280$0.290$0.280626,400
$0.2800.0000.0%$0.290$0.290$0.280306,800
$0.2800.0000.0%$0.280$0.290$0.2801,111,900
$0.280+0.010+3.7%$0.280$0.290$0.2701,768,500
$0.2700.0000.0%$0.280$0.280$0.270630,600
$0.2700.0000.0%$0.270$0.280$0.270449,900
$0.2700.0000.0%$0.270$0.280$0.270808,900
$0.2700.0000.0%$0.280$0.280$0.270523,700
$0.270-0.010-3.6%$0.290$0.300$0.2701,102,300
$0.2800.0000.0%$0.280$0.290$0.280681,600
$0.280-0.010-3.4%$0.280$0.290$0.280332,800
$0.290+0.010+3.6%$0.290$0.290$0.280540,500
$0.280+0.010+3.7%$0.270$0.280$0.270609,700
$0.270-0.020-6.9%$0.290$0.290$0.270507,100
$0.290+0.020+7.4%$0.270$0.290$0.270811,600
$0.2700.0000.0%$0.280$0.290$0.270713,500
$0.2700.0000.0%$0.270$0.280$0.270473,500
$0.270-0.010-3.6%$0.270$0.280$0.270501,000
$0.2800.0000.0%$0.280$0.280$0.270819,500
$0.2800.0000.0%$0.290$0.290$0.280413,600
$0.2800.0000.0%$0.290$0.290$0.280615,400
$0.280-0.010-3.4%$0.300$0.300$0.280344,900
$0.290-0.010-3.3%$0.300$0.300$0.290571,100
$0.3000.0000.0%$0.300$0.300$0.300372,600
$0.3000.0000.0%$0.300$0.300$0.300345,600
$0.3000.0000.0%$0.300$0.300$0.300457,000
$0.3000.0000.0%$0.300$0.310$0.300774,700
$0.300-0.010-3.2%$0.310$0.320$0.290619,100
$0.310-0.020-6.1%$0.330$0.340$0.310926,100
$0.330+0.020+6.5%$0.310$0.340$0.3103,598,300
$0.310+0.005+1.8%$0.310$0.310$0.300453,000
$0.305+0.004+1.3%$0.301$0.308$0.300387,273
$0.301-0.009-3.0%$0.310$0.310$0.300916,488
$0.310+0.030+10.7%$0.290$0.310$0.2801,867,400
$0.280-0.010-3.4%$0.290$0.290$0.270603,600

Splits

1 split · AMEX:IGC · every price before a split is adjusted for it

DayRatioWhat
1-for-10Consolidation
Ticker
Stuttgart:IGS1
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Stuttgart
Currency
EUR

What changed lately

Latest news

All IGC Pharma, Inc. news

IGC Pharma, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
39 in the last 12 months · 67 in all · newest Nov 18, 2026 · oldest 2025
Decks
14 decks · latest Jul 14, 2026

Where IGC Pharma, Inc. is listed

ListingExchangeCountryCurrency
NYSE American:IGC · Home listingNYSE AmericanUnited StatesUSD
gettex:IGS1gettexGermanyEUR
LS Exchange:A1T87ALS ExchangeGermanyEUR
Lang & Schwarz:A1T87ALang & SchwarzGermanyEUR
BOATS:IGCBOATSUnited StatesUSD
Dusseldorf:IGS1DusseldorfGermanyEUR
Frankfurt:IGS1FrankfurtGermanyEUR
Munich:IGS1MunichGermanyEUR
Stuttgart:IGS1 · This pageStuttgartGermanyEUR
Tradegate:IGS1TradegateGermanyEUR

Valuation

Price/book 3.0× against a median of 0.6×: 7th lowest of 8 Biotechnology companies shown. balance Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$19.19M USD
P/E
Not reported
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
3.0×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P 500
1.09

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
IGC Pharma, Inc. · AMEX:IGCUS$19.60MUS$19.19Mn/an/an/a3.0×n/a0.0×1.09
ZYUS Life Sciences Corporation · TSXV:ZYUSUS$20.92MUS$25.65Mn/a98.4×n/an/an/an/a-0.02
Xbrane Biopharma AB · OMXSTO:XBRANEUS$20.86MUS$23.45Mn/a1.9×n/a0.4×−49.0%0.1×n/a
Vivoryon Therapeutics N.V. · EURONEXT:VVYUS$20.48MUS$17.77Mn/an/an/a11.9×n/a0.1×n/a
Evaxion A/S · NASDAQ:EVAXUS$20.30MUS$13.40Mn/a1.8×n/a2.1×−115.1%0.8×0.78
Aardvark Therapeutics, Inc. · NASDAQ:AARDUS$20.20M−US$39.58Mn/an/an/a0.3×n/a0.0×3.28
GenSight Biologics SA · EURONEXT:SIGHTUS$20.19MUS$32.44Mn/a29,573×n/an/an/an/an/a
TransCode Therapeutics, Inc. · NASDAQ:RNAZUS$20.07MUS$15.44Mn/an/an/a0.6×n/a0.0×1.03
Adicet Bio, Inc. · NASDAQ:ACETUS$20.03MUS$5.02Mn/an/an/a0.2×n/a0.1×2.02
Provectus Biopharmaceuticals, Inc. · OTC:PVCTUS$19.12MUS$18.94Mn/an/an/an/an/an/a-0.21
LeonaBio, Inc. · NASDAQ:LONAUS$19.03M−US$12.82Mn/an/an/a1.2×n/a0.0×1.04
Median of the othersUS$20.19MUS$16.60M50.1×0.6×−82.1%0.1×1.03

Forecasts

2 strong buy · Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.

Price target
6.00 USD · Analysts' mean
EPS, year to Dec 2026
-0.10 · 1 analyst
Revenue, year to Dec 2026
958K · 1 analyst

Team and board

Officers

OfficerRole
Ram MukundaCEO & Director
Andres Sanchez/ Investor Relations
Claudia GrimaldiVP, CCO, PFO, & Director
Benysh QureshiDirector of Operations
Jose RamosCommunications Manager

Board

DirectorRole
Richard PrinsChairman
Claudia GrimaldiVP, CCO, PFO, & Director
Jim MoranDirector
Ram MukundaCEO & Director
Terry LiermanDirector

Events

QuarterResultsShare move
Q2 2027Nov 6, 2026 · After close+2.2%
Q1 2027Aug 14, 2026 · After close−6.7%
Q4 2026May 15, 2026 · After close0.0%
Quarter to Dec 31, 2025Feb 18, 2026+1.6%
Q2 2026Nov 14, 2025 · After close−5.6%
Q1 2026Aug 5, 2025 · After close−2.4%
Q4 2025Jun 27, 2025 · After close0.0%
Q3 2025Feb 14, 2025 · After close0.0%
Q2 2025Nov 12, 2024 · After close−2.6%
Q1 2025Aug 7, 2024 · After close0.0%
All 20 quarters
QuarterResultsShare move
Q4 2024Jun 24, 2024 · After close−8.5%
Q3 2024Feb 14, 2024 · After close0.0%
Q2 2024Nov 9, 2023 · After close0.0%
Q1 2024Aug 10, 2023 · After close+2.9%
Q4 2023Jun 30, 2023 · After close+3.2%
Q3 2023Feb 14, 2023 · After close0.0%
Q2 2023Nov 1, 2022 · After close−6.5%
Q1 2023Aug 5, 2022 · After close+5.5%
Q4 2022Jun 22, 2022 · After close−3.2%
Q3 2022Feb 10, 2022 · After close−6.4%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (July 2026)Investor deck25 slidesJul 14, 2026
Investor Presentation (June 2025)Investor deck50 slidesJun 17, 2025
FY2025 Earnings PresentationEarnings20 slidesJune 2025
Investor Presentation (April 2025)Investor deck28 slidesApril 2025
Investor Presentation (February 2024)Investor deck41 slidesFebruary 2024
Investor Presentation (January 2024)Investor deck29 slidesJanuary 2024
Investor Presentation (January 2024)Investor deck29 slidesJanuary 2024
Investor Presentation (August 2023)Investor deck36 slidesAug 2, 2023
Investor Presentation (February 2023)Investor deck25 slidesFeb 23, 2023
Investor Presentation (February 2023)Investor deck25 slidesFebruary 2023
All 14 decks
DeckKindSlidesDate
Investor Presentation (December 2022)Investor deck25 slidesDecember 2022
India Globalization Capital — Investor Presentation (February 2014)Investor deck14 slidesFeb 6, 2014
India Globalization Capital — Investor Presentation (June 2008)Investor deck8 slidesJun 4, 2008
India Globalization Capital — Merger or Acquisition (January 2008)Merger or acquisition28 slidesJan 29, 2008

Open Decks

Financings

RaiseDate
Registered direct offering of shares of common stock
Announced: about US$234,000 · US$0.3 a share
Use of proceeds: Working capital and general corporate purposes, including continued funding of the Phase 2 clinical program for IGC-AD1
Jan 5, 2026
Private placements and at-the-market offering
Closed: US$3.5M raised
Aug 19, 2025
Private placement of common shares
Announced: about US$475,000
Buyers: Frank Zaccanelli; Robert K. Coughlin; Joseph H. Mangan
Use of proceeds: General corporate purposes and advancing the CALMA Phase 2 clinical trial on agitation in Alzheimer's disease
Apr 24, 2025

Open Financings · Read by 6ix AI from the company's releases

IPO

Went public as India Globalization Capital, Inc., a blank check company (SPAC). Final prospectus filed on Mar 3, 2006.

Units offered
9,830,000 units
Underwriters' option
Up to 1,474,500 more units
Listing
IGC.U
Underwriters
Ferris, Baker Watts Incorporated, Ladenburg Thalmann & Co. Inc., First Albany Capital, Merriman Curhan Ford & Co., SOCIETE GENERALE · In the order on the cover
Units delivered
On or about Mar 8, 2006

Steps

StepWhen
Filed publiclyMay 13, 2005
Amended 7 timesNewest Mar 2, 2006
Shares registered with an exchangeMar 8, 2006
Final prospectus, with the priceMar 3, 2006

Open IPO · From the cover of the final prospectus (424B3) filed Mar 3, 2006

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue1.27M1.34M911.0K397.0K898.0K4.07M5.12M2.19M580.4K6.37M
Cost of revenue652.0K612.0K469.0K203.0K785.0K3.96M4.98M2.11M362.1K5.52M
Gross profit619.0K733.0K442.0K194.0K113.0K115.0K132.0K82.0K218.2K843.3K
Research and development3.65M3.77M3.46M2.33M929.0K1.01M1.26M137.0K
Selling, general and administrative4.41M6.76M8.55M13.3M7.91M5.97M3.52M1.73M2.27M2.70M
Operating income-7.45M-9.80M-11.6M-15.4M-8.72M-6.86M-4.64M-1.79M-2.05M-2.91M
Depreciation and amortization618.0K637.0K657.0K651.0K478.0K144.0K59.0K19.0K396.3K728.7K
EBITDA-6.83M-9.16M-10.9M-14.8M-8.25M-6.72M-4.58M-1.77M-1.66M-2.18M
Interest expense5.00K5.00K5.00K5.00K3.00K30.7K223.5K213.9K
Income before tax-7.12M-13.0M-11.5M-15.0M-8.81M-7.32M-4.09M-1.79M-1.84M-2.83M
Income tax0000002.00K014.4K579
Net income-7.12M-13.0M-11.5M-15.0M-8.81M-7.32M-4.10M-1.79M-1.87M-2.81M
Earnings per share, basic-0.09-0.22-0.22-0.29-0.21-0.19-0.13-0.06-0.07-0.17
Earnings per share, diluted-0.09-0.22-0.21-0.19-0.13-0.06-0.07-0.17

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents405.0K1.20M3.20M10.5M14.5M7.26M25.6M1.66M538.0K1.49M
Short-term investments00154.0K080.0K00148.0K1.88M0
Receivables34.0K39.0K107.0K125.0K175.0K133.0K84.0K558.0K752.9K962.7K
Inventory1.36M1.54M2.65M3.55M5.48M4.25M248.0K486.0K0162.1K
Current assets2.90M3.71M6.47M15.1M23.5M17.8M26.7M3.21M3.58M3.84M
Property, plant and equipment3.22M3.69M8.21M9.42M10.8M9.78M5.89M6.24M953.9K7.07M
Goodwill0198.2K1.18M
Total assets8.75M9.90M17.2M26.8M35.9M29.0M34.5M10.9M11.3M18.9M
Accounts payable883.0K773.0K530.0K981.0K476.0K762.0K319.0K258.0K
Current liabilities2.26M2.34M1.90M2.44M2.37M1.95M878.0K2.35M1.29M3.20M
Long-term debt134.0K137.0K141.0K144.0K276.0K0452.1K801.5K
Total debt137.0K140.0K144.0K147.0K580.0K50.0K452.1K829.2K
Total liabilities2.42M2.58M2.27M2.94M3.06M2.45M893.0K2.79M3.93M4.91M
Shareholders' equity6.33M7.32M14.9M23.9M32.8M26.5M33.6M8.06M7.36M13.5M
Shares outstanding80.9M66.7M53.1M51.1M47.8M39.3M39.5M30.8M28.3M23.3M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-4.79M-5.20M-7.05M-7.46M-10.8M-8.68M-3.33M-1.93M-1.39M-157.7K
Capital spending-112.0K-138.0K-310.0K-236.0K-1.47M-4.39M-15.0K-136.0K-145.7K-122.2K
Free cash flow-4.91M-5.34M-7.36M-7.70M-12.3M-13.1M-3.35M-2.07M-1.54M-279.9K
Cash from investing-442.0K-317.0K-235.0K-742.0K3.39M-9.55M-260.0K-657.0K-241.4K-183.4K
Cash from financing4.45M3.52M100.0K4.14M14.7M-59.0K27.6M3.71M707.6K1.01M
Change in cash-793.0K-2.00M-7.26M-4.09M7.29M-18.4M24.0M1.12M-952.7K666.2K

Open Financials

Filings

FilingDateTypeFiled with
10-Q · Quarterly reportNov 6, 2026Quarterly reportSEC
DEFA14A · Additional proxy materialOct 22, 2026Meeting noticeSEC
DEF 14A · Proxy statementOct 21, 2026Meeting noticeSEC
4 · Change in ownershipSep 29, 2026Insider tradeSEC
4 · Change in ownershipSep 29, 2026Insider tradeSEC
10-Q · Quarterly reportAug 14, 2026Quarterly reportSEC
8-K · Current reportJul 13, 2026Current reportSEC
8-K · Current reportJul 6, 2026Material contractSEC
4 · Change in ownershipJul 1, 2026Insider tradeSEC
4 · Change in ownershipJul 1, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
8-K · Current reportJun 8, 2026Material contractSEC
10-Q · Quarterly reportMay 15, 2026Quarterly reportSEC
8-K · Current reportApr 20, 2026Material contractSEC
4 · Change in ownershipApr 6, 2026Insider tradeSEC
4 · Change in ownershipApr 6, 2026Insider tradeSEC
4 · Change in ownershipApr 6, 2026Insider tradeSEC
4 · Change in ownershipApr 6, 2026Insider tradeSEC
8-K · Current reportMar 30, 2026Current reportSEC
10-KT · Transition reportMar 18, 2026Annual reportSEC
8-K · Current reportMar 11, 2026Material contractSEC
4 · Change in ownershipFeb 4, 2026Insider tradeSEC
4 · Change in ownershipJan 20, 2026Insider tradeSEC
8-K · Current reportJan 5, 2026Material contractSEC
424B5 · ProspectusJan 5, 2026Offer documentSEC
8-K · Current reportJan 2, 2026Current reportSEC
8-K · Current reportDec 15, 2025Current reportSEC
EFFECT · Notice that a registration is effectiveDec 8, 2025Other filingsSEC
CORRESP · Letter to the SECDec 4, 2025Other filingsSEC
S-3/A · Registration statement, amendedDec 3, 2025Offer documentSEC
S-3 · Registration statementNov 14, 2025Offer documentSEC
S-8 · Registration statement for employee plansNov 14, 2025Offer documentSEC
10-Q · Quarterly reportNov 14, 2025Quarterly reportSEC
8-K · Current reportNov 14, 2025Acquisition or disposalSEC
4 · Change in ownershipOct 22, 2025Insider tradeSEC
4 · Change in ownershipOct 21, 2025Insider tradeSEC
4 · Change in ownershipOct 21, 2025Insider tradeSEC
4 · Change in ownershipOct 21, 2025Insider tradeSEC
4 · Change in ownershipOct 20, 2025Insider tradeSEC
8-K · Current reportOct 10, 2025Meeting outcomeSEC
8-K · Current reportOct 1, 2025Material contractSEC
424B5 · ProspectusSep 19, 2025Offer documentSEC
DEFA14A · Additional proxy materialAug 18, 2025Meeting noticeSEC
DEF 14A · Proxy statementAug 18, 2025Meeting noticeSEC
10-Q · Quarterly reportAug 14, 2025Quarterly reportSEC
PRE 14A · Preliminary proxy statementAug 4, 2025Meeting noticeSEC
EFFECT · Notice that a registration is effectiveJul 29, 2025Other filingsSEC
CORRESP · Letter to the SECJul 24, 2025Other filingsSEC
UPLOAD · Letter from the SECJul 23, 2025Other filingsSEC
S-3 · Registration statementJul 18, 2025Offer documentSEC
10-K · Annual reportJun 27, 2025Annual reportSEC
8-K · Current reportJun 17, 2025Current reportSEC
5 · Annual statement of ownershipMay 15, 2025Insider tradeSEC
5 · Annual statement of ownershipMay 15, 2025Insider tradeSEC
5 · Annual statement of ownershipMay 15, 2025Insider tradeSEC
5 · Annual statement of ownershipMay 15, 2025Insider tradeSEC
10-Q · Quarterly reportFeb 14, 2025Quarterly reportSEC
10-Q · Quarterly reportNov 12, 2024Quarterly reportSEC
4 · Change in ownershipSep 27, 2024Insider tradeSEC
8-K · Current reportSep 27, 2024Material contractSEC
8-K · Current reportAug 26, 2024Meeting outcomeSEC
SC 13D/A · Big-stake notice, amendedAug 14, 2024Big-stake noticeSEC
4 · Change in ownershipAug 12, 2024Insider tradeSEC
144 · Notice of proposed saleAug 9, 2024Other filingsSEC
10-Q · Quarterly reportAug 7, 2024Quarterly reportSEC
UPLOAD · Letter from the SECAug 7, 2024Other filingsSEC
8-K · Current reportAug 2, 2024Material contractSEC
DEFA14A · Additional proxy materialJul 9, 2024Meeting noticeSEC
DEF 14A · Proxy statementJul 8, 2024Meeting noticeSEC
10-K · Annual reportJun 24, 2024Annual reportSEC
SC 13D · Big-stake noticeMay 21, 2024Big-stake noticeSEC
4 · Change in ownershipMay 13, 2024Insider tradeSEC
3 · Initial statement of ownershipMay 13, 2024Insider tradeSEC
EFFECT · Notice that a registration is effectiveMay 3, 2024Other filingsSEC
CORRESP · Letter to the SECApr 30, 2024Other filingsSEC
UPLOAD · Letter from the SECApr 19, 2024Other filingsSEC
S-3 · Registration statementApr 17, 2024Offer documentSEC
8-K · Current reportApr 5, 2024Current reportSEC
8-K · Current reportMar 27, 2024Material contractSEC
8-K · Current reportMar 21, 2024Material contractSEC
424B5 · ProspectusMar 21, 2024Offer documentSEC
4 · Change in ownershipMar 18, 2024Insider tradeSEC
4 · Change in ownershipMar 15, 2024Insider tradeSEC
4 · Change in ownershipMar 15, 2024Insider tradeSEC
4 · Change in ownershipMar 15, 2024Insider tradeSEC
144 · Notice of proposed saleMar 15, 2024Other filingsSEC
4 · Change in ownershipMar 15, 2024Insider tradeSEC
8-K · Current reportMar 13, 2024Management or board changeSEC
3 · Initial statement of ownershipMar 12, 2024Insider tradeSEC
10-Q · Quarterly reportFeb 14, 2024Quarterly reportSEC
424B5 · ProspectusJan 31, 2024Offer documentSEC
EFFECT · Notice that a registration is effectiveJan 9, 2024Other filingsSEC
CORRESP · Letter to the SECJan 4, 2024Other filingsSEC
UPLOAD · Letter from the SECJan 4, 2024Other filingsSEC
S-3 · Registration statementDec 29, 2023Offer documentSEC
10-Q · Quarterly reportNov 9, 2023Quarterly reportSEC
8-K · Current reportOct 27, 2023Material contractSEC
424B5 · ProspectusOct 27, 2023Offer documentSEC
EFFECT · Notice that a registration is effectiveOct 6, 2023Other filingsSEC
CORRESP · Letter to the SECOct 4, 2023Other filingsSEC
S-8 · Registration statement for employee plansOct 3, 2023Offer documentSEC
UPLOAD · Letter from the SECOct 3, 2023Other filingsSEC
S-3 · Registration statementSep 29, 2023Offer documentSEC
8-K · Current reportAug 21, 2023Meeting outcomeSEC
10-Q · Quarterly reportAug 10, 2023Quarterly reportSEC
DEF 14A · Proxy statementJul 26, 2023Meeting noticeSEC
10-K · Annual reportJul 7, 2023Annual reportSEC
8-K · Current reportJul 7, 2023Material contractSEC
8-K · Current reportJul 6, 2023Material contractSEC
NT 10-K · Late filing noticeJun 30, 2023Explanation requestSEC
4 · Change in ownershipJun 28, 2023Insider tradeSEC
4 · Change in ownershipJun 28, 2023Insider tradeSEC
4 · Change in ownershipJun 27, 2023Insider tradeSEC
4 · Change in ownershipJun 27, 2023Insider tradeSEC
5 · Annual statement of ownershipMay 12, 2023Insider tradeSEC
8-K · Current reportMay 5, 2023Management or board changeSEC
8-K · Current reportMar 21, 2023Current reportSEC
10-Q · Quarterly reportFeb 14, 2023Quarterly reportSEC
8-K · Current reportDec 29, 2022Management or board changeSEC
8-K · Current reportDec 20, 2022Current reportSEC
10-Q · Quarterly reportNov 1, 2022Quarterly reportSEC
8-K · Current reportSep 9, 2022Management or board changeSEC
10-Q · Quarterly reportAug 5, 2022Quarterly reportSEC
DEF 14A · Proxy statementJul 25, 2022Meeting noticeSEC
4 · Change in ownershipJun 28, 2022Insider tradeSEC
4 · Change in ownershipJun 28, 2022Insider tradeSEC
4 · Change in ownershipJun 28, 2022Insider tradeSEC
4 · Change in ownershipJun 28, 2022Insider tradeSEC
10-K · Annual reportJun 22, 2022Annual reportSEC
8-K · Current reportJun 9, 2022Current reportSEC
8-K · Current reportMay 12, 2022Material contractSEC
8-K · Current reportApr 18, 2022Current reportSEC
8-K · Current reportMar 23, 2022Management or board changeSEC
10-Q · Quarterly reportFeb 10, 2022Quarterly reportSEC
4 · Change in ownershipJan 28, 2022Insider tradeSEC
3 · Initial statement of ownershipJan 26, 2022Insider tradeSEC
8-K · Current reportJan 18, 2022Management or board changeSEC
4 · Change in ownershipDec 27, 2021Insider tradeSEC
4 · Change in ownershipDec 23, 2021Insider tradeSEC
4 · Change in ownershipDec 23, 2021Insider tradeSEC
S-8 · Registration statement for employee plansDec 22, 2021Offer documentSEC
8-K · Current reportDec 2, 2021Current reportSEC
8-K · Current reportNov 19, 2021Material contractSEC
10-Q · Quarterly reportOct 29, 2021Quarterly reportSEC
8-K · Current reportOct 15, 2021Management or board changeSEC
144 · Notice of proposed saleSep 17, 2021Other filingsSEC
DEF 14A · Proxy statementSep 15, 2021Meeting noticeSEC
3/A · Initial statement of ownership, amendedSep 15, 2021Insider tradeSEC
4/A · Change in ownership, amendedSep 15, 2021Insider tradeSEC
5/A · Annual statement of ownership, amendedSep 15, 2021Insider tradeSEC
10-Q · Quarterly reportAug 11, 2021Quarterly reportSEC
10-K · Annual reportJun 14, 2021Annual reportSEC
3 · Initial statement of ownershipJun 4, 2021Insider tradeSEC
4 · Change in ownershipMay 19, 2021Insider tradeSEC
5 · Annual statement of ownershipMay 17, 2021Insider tradeSEC
4 · Change in ownershipMay 14, 2021Insider tradeSEC
4 · Change in ownershipMay 14, 2021Insider tradeSEC
4 · Change in ownershipMar 10, 2021Insider tradeSEC
4 · Change in ownershipMar 8, 2021Insider tradeSEC
4 · Change in ownershipMar 8, 2021Insider tradeSEC
144 · Notice of proposed saleMar 2, 2021Other filingsSEC
10-Q · Quarterly reportFeb 12, 2021Quarterly reportSEC
EFFECT · Notice that a registration is effectiveFeb 1, 2021Other filingsSEC
POS AM · Amendment to an effective registrationJan 22, 2021Offer documentSEC
8-K · Current reportJan 13, 2021Management or board changeSEC
424B5 · ProspectusJan 13, 2021Offer documentSEC
8-K · Current reportJan 13, 2021Material contractSEC
EFFECT · Notice that a registration is effectiveJan 5, 2021Other filingsSEC
CORRESP · Letter to the SECDec 31, 2020Other filingsSEC
UPLOAD · Letter from the SECDec 31, 2020Other filingsSEC
S-3 · Registration statementDec 23, 2020Offer documentSEC
DEFA14A · Additional proxy materialDec 21, 2020Meeting noticeSEC
8-K · Current reportDec 21, 2020Current reportSEC
DEF 14A · Proxy statementDec 8, 2020Meeting noticeSEC
4 · Change in ownershipDec 4, 2020Insider tradeSEC
4 · Change in ownershipDec 2, 2020Insider tradeSEC
144 · Notice of proposed saleNov 30, 2020Other filingsSEC
10-Q · Quarterly reportNov 20, 2020Quarterly reportSEC
NT 10-Q · Late filing noticeNov 13, 2020Explanation requestSEC
8-K · Current reportAug 20, 2020Current reportSEC
10-Q · Quarterly reportAug 19, 2020Quarterly reportSEC
NT 10-Q · Late filing noticeAug 14, 2020Explanation requestSEC
8-K · Current reportAug 11, 2020Current reportSEC
8-K · Current reportJul 17, 2020Current reportSEC
10-K · Annual reportJul 10, 2020Annual reportSEC
NT 10-K · Late filing noticeJun 29, 2020Explanation requestSEC
5/A · Annual statement of ownership, amendedJun 15, 2020Insider tradeSEC
5/A · Annual statement of ownership, amendedJun 15, 2020Insider tradeSEC
5/A · Annual statement of ownership, amendedJun 15, 2020Insider tradeSEC
4 · Change in ownershipJun 15, 2020Insider tradeSEC
5 · Annual statement of ownershipMay 15, 2020Insider tradeSEC
5 · Annual statement of ownershipMay 15, 2020Insider tradeSEC
5 · Annual statement of ownershipMay 15, 2020Insider tradeSEC
8-K · Current reportMay 13, 2020Acquisition or disposalSEC
8-K · Current reportMay 7, 2020Current reportSEC
8-K · Current reportMar 26, 2020Current reportSEC
8-K · Current reportMar 13, 2020Current reportSEC
S-8 · Registration statement for employee plansFeb 25, 2020Offer documentSEC
10-Q · Quarterly reportFeb 10, 2020Quarterly reportSEC
8-K · Current reportJan 9, 2020Meeting outcomeSEC
DEF 14A · Proxy statementDec 13, 2019Meeting noticeSEC

This page holds 200 of 818 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from IGC Pharma, Inc.’s releases · as of Nov 3, 2026

Common shares
116,687,169
Fully diluted
116,687,169

Fully diluted

LineSharesAs of
Common shares116,687,169Nov 3, 2026

Share count over time

CountShares
Nov 3, 2026116,687,169

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Vanguard1.31M1.1%US$351KSep 30, 2026
Geode Capital1.04M0.89%US$280KSep 30, 2026
AdvisorShares Investments LLC939K0.81%US$253KSep 30, 2026
Citadel736K0.63%US$198KSep 30, 2026
BlackRock704K0.60%US$189KSep 30, 2026
Renaissance Technologies653K0.56%US$176KSep 30, 2026
State Street275K0.24%US$73,920Sep 30, 2026
Northern Trust170K0.15%US$45,787Sep 30, 2026
UBS98,7160.08%US$26,555Sep 30, 2026
Lawood & Co75,0000.06%US$20,168Sep 30, 2026
All 27 holders
HolderSharesOf the companyValueAs of
Goldman Sachs65,5410.06%US$17,624Sep 30, 2026
Dearborn Partners LLC59,4010.05%US$15,973Sep 30, 2026
Fisher Asset Management, LLC43,4000.04%US$11,670Sep 30, 2026
Truist Financial Corp36,6670.03%US$9,863Sep 30, 2026
Morgan Stanley35,1180.03%US$9,443Sep 30, 2026
Schneider Downs Wealth Management Advisors, LP30,0000.03%US$8,067Sep 30, 2026
Tower Research Capital LLC (TRC)16,6240.01%US$4,470Sep 30, 2026
Wealthcare Advisory Partners LLC10,000<0.01%US$2,689Sep 30, 2026
Burnham & Co LLC6,000<0.01%US$1,613Sep 30, 2026
Geneos Wealth Management Inc.3,000<0.01%US$810Sep 30, 2026
Group One Trading LLC1,806<0.01%US$486Sep 30, 2026
SimplyRIA Advisor Network200<0.01%US$54Sep 30, 2026
Farther Finance Advisors, LLC110<0.01%US$30Sep 30, 2026
Hurley Capital, LLC100<0.01%US$27Sep 30, 2026
Barclays4<0.01%US$1Sep 30, 2026
Triumph Capital Management2<0.01%US$1Sep 30, 2026
Smartleaf Asset Management LLC2<0.01%US$1Sep 30, 2026

Funds

HolderSharesOf the companyValueAs of
Vanguard Extended Market Index Fund815K0.70%US$222KJun 30, 2026
AdvisorShares Psychedelics ETF678K0.58%US$185KJun 30, 2026
Fidelity Extended Market Index Fund630K0.54%US$182KMay 31, 2026
Fidelity Total Market Index Fund98,5540.08%US$28,472May 31, 2026
Fidelity Series Total Market Index Fund95,3690.08%US$27,552May 31, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Richard Prins
Other companies: Amphastar Pharmaceuticals, Inc. (Lead Independent Director · Since at least Aug 19, 2024)
Chairman · Since at least Mar 31, 2025
Sudhakar V Shenoy
Other companies: GTT Communications Inc (Director · Oct 15, 2006 – Apr 15, 2008 · Past)
Director · Mar 2, 2006 – Jun 11, 2019 · Past
Andres Sanchez/ Investor Relations · Since at least Oct 13, 2026
Benysh QureshiDirector of Operations · Since at least Nov 4, 2026
Claudia GrimaldiVP, CCO, PFO, & Director · Since at least Jun 11, 2019
Jim MoranDirector · Since at least Jan 18, 2022
John CherinCFO, Treasurer and PAO · Mar 2, 2006 – Sep 1, 2017 · Past
Jose RamosCommunications Manager · Since at least Nov 4, 2026
Ram MukundaCEO & Director · Since at least Mar 2, 2006
Rohit GoelSenior Director of Finance&PAO · May 9, 2018 – May 13, 2021 · Past
All 11 people
PersonSeat
Terry LiermanDirector · Since at least Mar 12, 2024

Open People

Log in to ask 6ix AI your own questions about IGC Pharma, Inc.